Tagged Articles

sleep apnea 47 articles

Study finds many men can restore testosterone levels with diet and exercise

Doctors should encourage overweight, middle-aged, and pre-diabetic men to lose weight through diet and exercise before putting them on testosterone replacement therapy, says the author of a new study presented at the a Houston medical conference. Dr. Frances Hayes, a professor at St. Vincent’s University Hospital in Dublin, Ireland, said that men who suffer from low testosterone levels can restore their hormones by nearly 50 percent by adhering to a healthier, more active lifestyle. The study monitored 900 American men with an average age of 54 who had been diagnosed with impaired glucose tolerance, or pre-diabetes. The men, all of ... Read More

Improper exposure to, use of Testosterone drugs can be harmful

The sharp upswing in sales of Androgel,Testim and other hormone-replacement drugs in recent years indicates record numbers of American men are seeking a boost in their testosterone levels. But while men who use these drugs may experience some relief from age-related declines in strength and libido, among other benefits, the drugs may also work behind the scenes to create a number of harmful side effects that may not be so easily or readily noticeable at first. Some of the most commonly reported side effects of topical testosterone drugs, which are usually applied to the shoulders, upper arms, or abdomen, are ... Read More

Study blames surge in testosterone drug sales on “disease mongering” marketing

Testosterone replacement drugs are surging in popularity in Australia and Canada, thanks to slick promotional campaigns and “disease mongering” by pharmaceutical companies, said the author of a new study published in the Medical Journal of Australia (MJA). In the study, David Handelsman, director of the ANZAC Research Institute at the University of Sydney, examined patterns in testosterone drug prescribing in Australia from 1992 to 2010. He found total expenditures on testosterone prescriptions more than doubled in that time period after taking into account inflation and population growth, yet there was no correlating increase in the number of approved uses for ... Read More

Testim maker poised to expand its share of men’s health market

Bolstered by soaring demand for testosterone replacement products, a deal with GlaxoSmithKline to market its top drug Testim, and now favorable results of a new drug study to treat penile curvature, things are looking up for Auxilium Pharmaceuticals. Reuters reports that shares of Auxilium, a small drug company based in Malvern, Pennsylvania, shot up 17 percent Monday on news that two late-stage trials indicated its drug Xiaflex reduced curvature of the penis by more than 30 percent in men with Peyronie’s Disease, a condition caused when excessive collagen protein deposits create curvature and sometimes painful erections. Xiaflex is already approved ... Read More

Study links sleep apnea to type 2 diabetes

People who suffer from sleep apnea are more likely to suffer from type 2 diabetes  than people who have a more restful night’s sleep, according to a new study presented at the American Thoracic Society (ATS) 2012 International Conference. Researchers also concluded that low oxygen levels in the blood during sleep hours, a symptom of sleep apnea, is linked to levels of glycosylated hemoglobin (HbA1c), a targeted indicator for diabetes. Previous studies have linked sleep apnea and sleep disturbances to a higher risk for type 2 diabetes. In 2007, a study from Yale showed the risk of diabetes among people ... Read More

Testosterone wars heat up as Testim maker allies with GlaxoSmithKline

Testim manufacturer Auxilium Pharmaceuticals Inc. of Malvern, Pennsylvania, has entered a partnership with GlaxoSmithKline to drive up sales of the testosterone drug, the companies announced this week. Testim is a topical gel containing one percent testosterone, prescribed as a hormone-replacement therapy for men with clinically low testosterone levels and the physical slow-down that generally accompanies “low T,” as the condition is sometimes called. Testim and other testosterone replacement therapies are also sought after by men who take the drug for recreational purposes. The effects of excessive testosterone in men are virtually the same as taking steroids, with increased muscle mass ... Read More

People with sleep apnea more likely to die from cancer

An estimated 28 million Americans have sleep apnea, a sleep disorder characterized by abnormal pauses in breathing or instances of abnormally low breathing, during sleep. A new study suggests that people who suffer from the condition may be five times more likely to die from cancer. Older studies have already linked sleep apnea to an increased risk for heart attacks, strokes and diabetes. The new study, published in an upcoming issue of the American Journal of Respiratory and Critical Care Medicine, has added another terrifying health issue – cancer – to the list. For the study, researchers examined 22 years ... Read More

Drugmakers credit Androgel and Testim for first-quarter profit surge

The market for testosterone replacement drugs is booming, with no signs of easing in the future, market analysts say. Abbott Laboratories, the maker of Androgel 1.62% and Androgel 1% and Auxilium Pharmaceuticals, which makes Testim 1%, are aggressively marketing their testosterone drugs to millions of men in the U.S. with low testosterone levels, and those efforts are paying off. Sales of testosterone replacement drugs hit $1.6 billion in 2011, up 133 percent in just four years. According to data compiled by Bloomberg analysts, 5.6 million prescriptions were written for testosterone replacement therapies last year and sales are expected to triple ... Read More

NJ doctor may lose license for inappropriate testosterone replacement and painkiller prescriptions

The New Jersey Attorney General’s Office has moved to suspend the medical license of a doctor who, investigators allege, indiscriminately prescribed potent testosterone replacement drugs such as Androgel in addition to powerful prescription pain medications, including OxyContin and Roxicodone when they weren’t appropriate and necessary for patients to take. According to Newark’s Star-Ledger, Dr. Roger Lallemand Jr. wrote thousands of such prescriptions for patients visiting the three offices he maintained in Old Bridge and Asbury Park, New Jersey. The doctor told one patient, an undercover investigator with the U.S. Drug Enforcement Administration, that he offered testosterone drugs to all of ... Read More

Appeals judges side with Big Pharma in Androgel case

A U.S. appeals court in Atlanta sided with Big Pharma in an April ruling, allowing “pay-for-delay” arrangements between brand-name and generic drug manufacturers. At the center of this ruling was the testosterone drug Androgel, a blockbuster drug made by Brussels-based Solvay (now Abbott Pharmaceuticals) that brought in $594 million in 2010 and promises explosive growth in the future as more and more men turn to it for its sexually restorative effects. Solvay was originally granted a 17-year patent in 2003, which barred other drugmakers from developing a generic version of the topical gel until 2015. However, three drug companies challenged ... Read More